These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 21073432

  • 1. Recent developments in therapeutic approaches for lysosomal storage diseases.
    Urbanelli L, Magini A, Polchi A, Polidoro M, Emiliani C.
    Recent Pat CNS Drug Discov; 2011 Jan; 6(1):1-19. PubMed ID: 21073432
    [Abstract] [Full Text] [Related]

  • 2. New strategies for the treatment of lysosomal storage diseases (review).
    Parenti G, Pignata C, Vajro P, Salerno M.
    Int J Mol Med; 2013 Jan; 31(1):11-20. PubMed ID: 23165354
    [Abstract] [Full Text] [Related]

  • 3. Personalized Pharmacoperones for Lysosomal Storage Disorder: Approach for Next-Generation Treatment.
    Haneef SA, Doss CG.
    Adv Protein Chem Struct Biol; 2016 Jan; 102():225-65. PubMed ID: 26827607
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic approaches for lysosomal storage diseases: a patent update.
    Urbanelli L, Sagini K, Polidoro M, Brozzi A, Magini A, Emiliani C.
    Recent Pat CNS Drug Discov; 2013 Aug; 8(2):91-109. PubMed ID: 23713988
    [Abstract] [Full Text] [Related]

  • 5. Treatment of lysosomal storage diseases: recent patents and future strategies.
    Ortolano S, Viéitez I, Navarro C, Spuch C.
    Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):9-25. PubMed ID: 24433521
    [Abstract] [Full Text] [Related]

  • 6. Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics.
    Parenti G.
    EMBO Mol Med; 2009 Aug; 1(5):268-79. PubMed ID: 20049730
    [Abstract] [Full Text] [Related]

  • 7. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective.
    Thomas R, Kermode AR.
    Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228
    [Abstract] [Full Text] [Related]

  • 8. Lysosomal storage diseases: from pathophysiology to therapy.
    Parenti G, Andria G, Ballabio A.
    Annu Rev Med; 2015 Feb; 66():471-86. PubMed ID: 25587658
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders.
    Parenti G, Andria G, Valenzano KJ.
    Mol Ther; 2015 Jul; 23(7):1138-1148. PubMed ID: 25881001
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications.
    Biffi A.
    Mol Ther; 2017 May 03; 25(5):1155-1162. PubMed ID: 28389320
    [Abstract] [Full Text] [Related]

  • 13. Enzyme Replacement Therapy: A Review and Its Role in Treating Lysosomal Storage Diseases.
    Li M.
    Pediatr Ann; 2018 May 01; 47(5):e191-e197. PubMed ID: 29750286
    [Abstract] [Full Text] [Related]

  • 14. Treatment strategies for lysosomal storage disorders.
    Beck M.
    Dev Med Child Neurol; 2018 Jan 01; 60(1):13-18. PubMed ID: 29090451
    [Abstract] [Full Text] [Related]

  • 15. Treatment options for lysosomal storage disorders: developing insights.
    van Gelder CM, Vollebregt AA, Plug I, van der Ploeg AT, Reuser AJ.
    Expert Opin Pharmacother; 2012 Nov 01; 13(16):2281-99. PubMed ID: 23009070
    [Abstract] [Full Text] [Related]

  • 16. Treatment for Lysosomal Storage Disorders.
    Sheth J, Nair A.
    Curr Pharm Des; 2020 Nov 01; 26(40):5110-5118. PubMed ID: 33059565
    [Abstract] [Full Text] [Related]

  • 17. Update on treatment of lysosomal storage diseases.
    Bruni S, Loschi L, Incerti C, Gabrielli O, Coppa GV.
    Acta Myol; 2007 Jul 01; 26(1):87-92. PubMed ID: 17915580
    [Abstract] [Full Text] [Related]

  • 18. [Therapy of lysosomal storage diseases: update and perspectives].
    Lara-Aguilar RA, Juárez-Vázquez CI, Medina-Lozano C.
    Rev Invest Clin; 2011 Jul 01; 63(6):651-8. PubMed ID: 23650678
    [Abstract] [Full Text] [Related]

  • 19. Advances in therapies for neurological lysosomal storage disorders.
    Ellison S, Parker H, Bigger B.
    J Inherit Metab Dis; 2023 Sep 01; 46(5):874-905. PubMed ID: 37078180
    [Abstract] [Full Text] [Related]

  • 20. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I.
    Penati R, Fumagalli F, Calbi V, Bernardo ME, Aiuti A.
    J Inherit Metab Dis; 2017 Jul 01; 40(4):543-554. PubMed ID: 28560469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.